Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Life & Style What happens 80 millions times during a 10-second kiss? Differences between bacteria and virus
BVSC General Director criticizes zero-fee policy, emphasises impact on revenue in competitive market 1.